- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD70-positive Advanced Urologic Neoplasms
Total 13672 results
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Merck Sharp & Dohme LLCTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPain | Advanced Malignant NeoplasmUnited States
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Israel, Australia, Austria, Canada, Italy
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerAdvanced Kidney CancerChina
-
University Hospital, BordeauxCompletedCarcinoma, Renal Cell | Malignant Advanced Solid TumorsFrance
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); PfizerCompletedNeoplasms, AdvancedUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Locally Advanced Malignant Solid Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Locally Advanced Clear Cell Renal Cell CarcinomaUnited States
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States, Czechia, Serbia
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedFatigue | Advanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Rare Malignant Solid Neoplasm | Rare Malignant Solid Neoplasm | Refractory Rare Malignant Solid NeoplasmUnited States
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Renal Cell Carcinoma
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedAdvanced Renal Cell CarcinomaUnited States
-
IpsenCompletedAdvanced Renal Cell CarcinomaUnited Kingdom
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
PfizerCompletedAdvanced Renal Cell CarcinomaKorea, Republic of, Japan, China
-
Pharmacyclics LLC.CompletedMetastatic Renal Cell Carcinoma | Metastatic Colorectal Adenocarcinoma | Advanced Gastric Adenocarcinoma | Advanced Urothelial CarcinomaUnited States, Korea, Republic of, Spain, United Kingdom
-
Genomictree, Inc.Samsung Medical Center; Pusan National University Hospital; Asan Medical Center; Seoul National University Hospital and other collaboratorsRecruitingColorectal Cancer | Advanced Colorectal Neoplasm | Advanced Adenomas | Non-neoplastic Polyps | Non-advanced AdenomasKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
SLK Kliniken Heilbronn GmbHRecruitingAdvanced Renal Cell CarcinomaGermany
-
Spanish Oncology Genito-Urinary GroupGlaxoSmithKlineCompletedAdvanced Renal Cell CarcinomaSpain
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
AmgenCompleted
-
University Hospital TuebingenUnknownRenal Cell Cancer | Advanced Renal Cell Cancer
-
AmgenCompletedAdvanced Renal Cell Carcinoma
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Belgium
-
Center Eugene MarquisCompletedLocally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and NeckFrance
-
DualityBio Inc.RecruitingHER2-positive Advanced Solid TumorChina, United States, Australia, Puerto Rico
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Calithera Biosciences, IncTerminatedAdvanced Nonhematological NeoplasmsKorea, Republic of, Japan, Taiwan
-
ExelixisArcus Biosciences, Inc.RecruitingAdvanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid TumorsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
University of Colorado, DenverAmerican Cancer Society, Inc.Recruiting
-
Michael B. Atkins, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruitingAdvanced Renal Cell CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
AmgenCompletedAdvanced Renal Cell Carcinoma
-
AmgenCompletedAdvanced Renal Cell Carcinoma
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Canada
-
Inge Marie SvaneCompleted
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
-
Institut Paoli-CalmettesCancer Research Center of MarseilleActive, not recruitingUrologic Neoplasms | Lung Cancer Metastatic | Non Hodgkin Lymphoma | Locally Advanced Malignant NeoplasmFrance
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic TherapeuticsRecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent AdenocarcinomaUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
AstraZenecaTerminated
-
National Cancer Institute (NCI)Not yet recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
Cancer Institute and Hospital, Chinese Academy...CompletedLocally Advanced Malignant NeoplasmChina